Kaiseraugst (Switzerland), October 19th, 2023
dsm-firmenich, the leading innovator in health, nutrition and beauty, today announces the upcoming North American launch of life’s®OMEGA O3020, the first and only single-source algal omega-3 with the same eicosapentaenoic acid (EPA) to docosahexaenoic acid (DHA) ratio naturally found in standard fish oil, but with twice the potency.
life’s®OMEGA O3020 has a ratio of 1.5:1 EPA to DHA and will offer dietary supplement brands an easier path to converting or expanding their existing fish-based omega-3 portfolio, using a more sustainable algal source, while providing greater flexibility in addressing key health concerns to enhance consumer appeal.
With the marine omega-3 category facing ongoing supply challenges due to climate and environmental impacts that limit the availability of traditional fish oil, the launch of life’s®OMEGA O3020 demonstrates dsm-firmenich’s continued commitment to the supply of sustainable algal omega-3 solutions, while creating options for customers and consumers.
“The pending launch of life’s®OMEGA O3020 marks another milestone in the development of our unique life’s® portfolio, which has the potential to truly transform the omega-3 market,” comments Brent MacDonald, Director Global Product Marketing at dsm-firmenich. “This highly concentrated plant-based EPA and DHA solution will support greater supply security and help our customers achieve their sustainability goals, especially as life’s®OMEGA is produced in a controlled and closed environment, with zero impact on marine ecosystems. We will continue to innovate and expand our life’s portfolio, offering our partners and consumers more options to meet their market and nutritional needs.”
“It has been estimated that 80% of the world’s population does not consume the daily omega-3 amounts recommended by experts ,” adds Chris Kalodis, Marketing Manager at dsm-firmenich. “Algal-based EPA and DHA sources can play an essential role in addressing these deficiencies worldwide, offering alternatives to consumers - without compromise - when making nutritional choices. We continue to invest heavily in research and development in this space to ensure greater choice for our customers and their consumers – without compromising on quality or product performance.”
Omega-3s are one of the world’s most popular nutrients, recognized not only for their role in cardiovascular health, but for their brain and eye health benefits as well. Moreover, a growing body of evidence indicates the multiple benefits of omega-3s in specific and trending areas of brain health, including cognitive performance, mood, mental well-being and sleep.
dsm-firmenich’s life’s®OMEGA is the only commercially-available, algal-based omega-3 that delivers EPA and DHA from a single quality source. life’s®OMEGA solutions are manufactured using proprietary precision fermentation of a natural, non-GMO algae grown in a controlled, enclosed and inland environment to ensure purity, with multiple production locations ensuring a reliable supply.
life’s®OMEGA O3020 will first launch in North America and is expected to achieve regulatory clearance in the U.S. as early as January 2024.
As a purpose-led, end-to-end partner, dsm-firmenich is committed to supporting the development of innovative omega-3 solutions from concept to consumer. Offering access to a broad portfolio of science-based products, customized solutions such as Market-ready Solutions and expert services at every stage of the development process, dsm-firmenich helps brands launch and scale up purpose-driven nutritional lipid products to attract a new generation of consumers.
To learn more about dsm-firmenich’s life’s® portfolio, visit www.dsm.com/lifes-omega
As innovators in nutrition, health, and beauty, dsm-firmenich reinvents, manufactures, and combines vital nutrients, flavors, and fragrances for the world’s growing population to thrive. With our comprehensive range of solutions, with natural and renewable ingredients and renowned science and technology capabilities, we work to create what is essential for life, desirable for consumers, and more sustainable for the planet. dsm-firmenich is a Swiss-Dutch company, listed on the Euronext Amsterdam, with operations in almost 60 countries and revenues of more than €12 billion. With a diverse, worldwide team of nearly 30,000 employees, we bring progress to life™ every day, everywhere, for billions of people. www.dsm-firmenich.com
This press release may contain forward-looking statements with respect to dsm-firmenich’s future (financial) performance and position. Such statements are based on current expectations, estimates and projections of dsm-firmenich and information currently available to the company. dsm-firmenich cautions readers that such statements involve certain risks and uncertainties that are difficult to predict and therefore it should be understood that many factors can cause actual performance and position to differ materially from these statements. dsm-firmenich has no obligation to update the statements contained in this press release, unless required by law. The English language version of this press release prevails over other language versions.